BPC
EW icon

Banque Pictet & Cie’s Edwards Lifesciences EW Stock Holding History

Banque Pictet & Cie’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Sell
21,262
-837
-4% -$70.1K 0.01% 200
2026
Q1 		$1.77M Sell
22,099
-78,812
-78% -$6.5M 0.01% 228
2025
Q4 		$8.6M Buy
100,911
+1,290
+1% +$106K 0.05% 122
2025
Q3 		$7.75M Sell
99,621
-39,344
-28% -$3.07M 0.05% 125
2025
Q2 		$10.9M Sell
138,965
-48,150
-26% -$3.59M 0.08% 97
2025
Q1 		$13.6M Buy
187,115
+30,147
+19% +$2.16M 0.11% 79
2024
Q4 		$11.6M Buy
156,968
+80,851
+106% +$5.66M 0.08% 89
2024
Q3 		$5.02M Buy
+76,117
New +$5.53M 0.04% 144
2023
Q4 		– Sell
-14,639
Closed -$1.01M – 393
2023
Q3 		$1.01M Sell
14,639
-2,480
-14% -$199K 0.01% 278
2023
Q2 		$1.61M Sell
17,119
-88,916
-84% -$7.73M 0.01% 269
2023
Q1 		$8.77M Buy
106,035
+2,391
+2% +$188K 0.09% 113
2022
Q4 		$7.73M Sell
103,644
-17,462
-14% -$1.35M 0.08% 123
2022
Q3 		$10M Sell
121,106
-13,593
-10% -$1.31M 0.11% 100
2022
Q2 		$12.8K Sell
134,699
-10,066
-7% -$1.04M 0.13% 86
2022
Q1 		$17M Sell
144,765
-10,254
-7% -$1.15M 0.13% 86
2021
Q4 		$20.1M Buy
155,019
+136,116
+720% +$15.9M 0.15% 82
2021
Q3 		$2.14M Sell
18,903
-1,443
-7% -$165K 0.02% 195
2021
Q2 		$2.11M Buy
20,346
+838
+4% +$79K 0.02% 199
2021
Q1 		$1.63M Buy
19,508
+14,438
+285% +$1.22M 0.02% 211
2020
Q4 		$463K Sell
5,070
-813
-14% -$67.4K 0.01% 271
2020
Q3 		$470K Buy
5,883
+1,341
+30% +$105K 0.01% 259
2020
Q2 		$314K Buy
4,542
+210
+5% +$14.9K 0.01% 286
2020
Q1 		$272K Sell
4,332
-4,221
-49% -$304K 0.01% 296
2019
Q4 		$665K Hold
8,553
– – 0.01% 272
2019
Q3 		$627K Hold
8,553
– – 0.01% 251
2019
Q2 		$527K Hold
8,553
– – 0.01% 256
2019
Q1 		$545K Sell
8,553
-2,295
-21% -$131K 0.01% 254
2018
Q4 		$554K Sell
10,848
-1,350
-11% -$68.3K 0.01% 258
2018
Q3 		$708K Sell
12,198
-1,125
-8% -$55K 0.01% 261
2018
Q2 		$646K Hold
13,323
– – 0.01% 253
2018
Q1 		$620K Buy
13,323
+7,143
+116% +$310K 0.01% 267
2017
Q4 		$232K Sell
6,180
-75,300
-92% -$2.76M ﹤0.01% 330
2017
Q3 		$2.97M Hold
81,480
– – 0.07% 180
2017
Q2 		$3.21M Sell
81,480
-9,900
-11% -$361K 0.08% 163
2017
Q1 		$2.87M Buy
91,380
+41,580
+83% +$1.3M 0.07% 164
2016
Q4 		$1.55M Buy
49,800
+42,900
+622% +$1.39M 0.04% 200
2016
Q3 		$277K Sell
6,900
-1,800
-21% -$67.8K 0.01% 297
2016
Q2 		$289K Hold
8,700
– – 0.01% 295
2016
Q1 		$256K Hold
8,700
– – 0.01% 296
2015
Q4 		$229K Hold
8,700
– – 0.01% 297
2015
Q3 		$206K Buy
+8,700
New +$210K 0.01% 343
2015
Q2 		– Sell
-11,100
Closed -$264K – 370
2015
Q1 		$264K Hold
11,100
– – 0.01% 402
2014
Q4 		$236K Sell
11,100
-900
-8% -$18.1K 0.01% 404
2014
Q3 		$204K Buy
+12,000
New +$189K 0.01% 426

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Banque Pictet & Cie's EW Position: Q2 2026 in Review

Banque Pictet & Cie reduced its Edwards Lifesciences (EW) stake by 3.8% in Q2 2026, selling an estimated $70.1K and leaving 21,262 shares worth $1.92M. The position accounts for 0.01% of the portfolio, ranked #200.

Banque Pictet & Cie first reported a position in EW in Q3 2014 and has held it in 44 quarters since. The position peaked at $20.1M in Q4 2021. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Banque Pictet & Cie held 21,262 shares of Edwards Lifesciences worth $1.92M as of Q2 2026.
  • Banque Pictet & Cie sold 837 Edwards Lifesciences shares in Q2 2026, an estimated $70.1K.
  • Edwards Lifesciences made up 0.01% of Banque Pictet & Cie's portfolio in Q2 2026, its #200 holding.
  • Banque Pictet & Cie first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 44 quarters since.
  • Banque Pictet & Cie's Edwards Lifesciences position peaked at $20.1M in Q4 2021.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.